Ulcerative Colitis Market PowerPoint PPT Presentations

During the forecast period from 2012 - 2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada.

During the forecast period from 2012-2022, the growth of the ulcerative colitis market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. See More: http://goo.gl/tW6DQL

Ulcerative colitis is a chronic disease that affects the colon of large intestine. It is characterized by inflammation in the large intestine, and the symptoms include blood in the stool, diarrhea and abdominal pain.

The Business Research Company offers ulcerative colitis market research report 2023 with industry size, share, segments and market growth

http://www.gosreports.com/global-portable-gps-market-research-report-2016/ http://www.gosreports.com/global-car-bluetooth-market-research-report-2016/ Usefull data ：Ulcerative Colitis market research 2020 by Gosreports

An interactive excel forecast model based on primary research interviews and surveys with KOLs and high-prescribing physicians is included in this report

Treating Ulcerative Colitis

Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory Bowel Disease (IBD). The disease is characterized by open sores and ulcers in the colon. 

Aarkstore Market Research published the new epoch of Market Research Report "Global Pharmaceutical Packaging Equipment Market"

TNF alpha inhibitors refer to medications that are used to treat inflammatory diseases such as rheumatoid arthritis (RA), psoriatic arthritis, and juvenile idiopathic arthritis and that help to reduce or eliminate inflammation. TNF inhibitors may increase the risk of skin cancer, particularly non-melanoma skin cancers like squamous cell carcinoma.

This report provides comprehensive information on the therapeutic development for Ulcerative Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Browse full report @ http://goo.gl/mgiA4M

This Report provided by 24 Market Reports is about, the EMEA Sulfasalazine Tablets market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms.

Colonoscopes Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography

Global Adalimumab, Infliximab and Etanercept Biosimilars Market by The Business Research Company is segmented as Crohn’S Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis https://bit.ly/3CA170z

Methylprednisolone is a medication commonly known as Depo-Medol and Solu-Medol; it is a corticosteroid medication utilized to contain immune system responses that cause inflammation. It is used to treat various types of inflammatory conditions such as lupus, arthritis, psoriasis, ulcerative colitis, gland disorders, and different types of conditions affecting skin, lungs, stomach, and nervous system. The medication is given orally or into the vein or muscle.

The stoma care market size was USD 558.37 million in 2022 and is expected to register a rapid revenue CAGR of 7% during the forecast period. Increasing prevalence of chronic disorders, such Crohn's disease, Ulcerative Colitis, and colon cancer and aging population, due to which bladder cancer and bowel cancer have become more common, are major factors driving market revenue growth.

Inflammatory Bowel Disease Market Size is estimated to reach $26.3 billion by 2027 and is poised to grow at a CAGR of 5.9% over the forecast period of 2022-2027. Inflammatory bowel disease (IBD) is an umbrella term used to describe disorders that involve chronic inflammation of the digestive tract. It includes ulcerative colitis, a condition in which inflammation and soreness of the superficial lining of the rectum and colon, and in Crohns disease affect any part of the gastrointestinal tract.

Big Market Research “Global Inflammatory Bowel Disease Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast. Visit for more info @ http://www.bigmarketresearch.com/global-inflammatory-bowel-disease-2015-2019-market Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a specific part or the entire GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss.

Ileostomy is the surgical procedure an opening is created using surgical devices in the ileum, which is the lowest part of the small intestine and then aligned such that it gets attached with the abdominal wall. The intestinal part is basically brought through to the abdominal wall for the formation of stoma. The customization can be done for permanent or temporary basis and may help in removal of all or a particular part of the colon. The ileostomy is carried out to assist with the removal of the waste from the body. The surgery is carried out when the part of the rectum or colon is not working. The surgical procedures include total abdominal colectomy, total proctocolectomy, and small bowel resection.

The ostomy drainage bags market was valued at $2,742 million in 2015, and is expected to reach $3,524 million by 2022, growing at a CAGR of 3.6% from 2016 to 2022.High prevalence of colorectal cancer owing to the increase in geriatric population drives the market growth. Increase in population prone to colon cancer, urinary tract cancer, bladder cancer, colorectal cancer, inflammatory bowel disease, and chronic diseases such as ulcerative colitis and Crohns disease that require ostomy surgery, further boosts the market growth.

The global mesalamine market size is estimated to grow from USD 169.5 million in 2020 and reach USD 211.6 million by 2027, at a CAGR of 3.4% over the forecast period, 2021-2027. Mesalamine, also known as Mesalazine, is a prescription drug containing 5-aminosalicylic acid that helps cure ulcerative colitis (UC) and other inflammatory bowel disorders. Mesalamine is known as the first-line agent for the treatment of active UC and preservation of clinical recovery. It has been reported as the active anti-inflammatory agent used since the 1940s to treat UC. Several different types of mesalamine medications can be distinguished based on their means of delaying mesalamine release until it reaches the colon.

Bael churna contains laxative properties that help to treat constipation. It is highly effective in treating dysentery, diarrhea, IBS, IBD, Ulcerative colitis and all other gastrointestinal problems. Bilva powder is a great herbal supplement to maintain healthy functioning of the heart. It offer relief from palpitation, anxiety and nervousness.

According to Crohn’s & Colitis UK, around 300,000 people suffer from crohn’s disease and ulcerative colitis in the UK annually.[1] Malnourishment is the common cause of inflammatory bowel disease (IBD) among a large section of people in both under-developed and developing countries.

Inflammatory Bowel Disease Market

Nicotine USP, or United States Pharmacopeia-grade nicotine, is a high-purity form of nicotine that is used in a variety of pharmaceutical and industrial applications. The global nicotine USP market is expected to grow from USD 392.9 million in 2021 to USD 1,022.17 million by 2030, at a CAGR of 7.5% during the forecast period.

Data Bridge Market Research analyzes that the Asia-Pacific stool diagnostic market is expected to reach USD 452,156.67 thousand by 2030, at a CAGR of 7.1% during the forecast period. https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-stool-diagnostic-market

Market Size – USD 30.57 Billion in 2021, Market Growth – at a CAGR of 5.4%, Market Trends – Evolution in the techniques to diagnose cancer

The global medical tapes and bandages market size is expected to exhibit a growth rate (CAGR) of 3.29% during 2024-2032.

As per Renub Research, report titled “Colonoscopy Devices Market Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” the Global Colonoscopy Devices Market is expected to be USD 2.1 Billion by 2027. Globally, Colonoscopy devices are used to examine the inside of the colon using a colonoscope inserted into the rectum. Wherein, colonoscope implies a thin, tube-like instrument with a light and a lens for viewing. Besides, a colonoscopy may also have a tool to remove tissue to be checked under a microscope for signs of disease. In addition, the gastroenterologist carefully guides the colonoscope in various directions to look inside the colon. After that, a picture from the camera appears on a monitor to provide a clear, magnified view of the colon lining.

The global mesalamine market size is estimated to grow from USD 169.5 million in 2020 and reach USD 211.6 million by 2027, at a CAGR of 3.4% over the forecast period, 2021-2027.

Adalimumab Market Size is estimated to reach $5.1 billion by 2027. Furthermore, it is poised to grow at a CAGR of 5.1% over the forecast period of 2022-2027.

The Crohn’s & Colitis Foundation of America (CCFA) stated that over 1 Million Americans were diagnosed with Crohn’s & ulcerative colitis disorders, with most of them aged above 30. Growing occurrence of Crohn’s disease has triggered a robust demand for its therapeutics. A survey conducted by the US Center for Disease Control (CDC) has revealed that the incidence rate of Crohn’s disease in the country is 3.1 to 14.6 new cases per 100,000 population annually.

According to the Market Statsville Group (MSG), the global metal in medicine market is estimated to grow at a CAGR of 12.4% from 2022 to 2030.

The global ostomy drainage bags market was valued at $1,658.38 million in 2020, and is projected to reach $2,409.38 million by 2030, growing at a CAGR of 3.8% from 2021 to 2030.

The Probiotic Ingredients Market size is estimated to reach $3.4 billion in 2021, growing at a CAGR of 8.1% during the forecast period 2022-2027.

Gastrointestinal diseases include conditions such as gastroesophageal reflux disease, inflammatory bowel disease, Crohn’s disease, peptic ulcer disease, irritable bowel syndrome, gastric cancer, ulcerative colitis and others.

Ustekinumab Market

The Global Probiotic Supplements market is projected to grow at a CAGR of around 4.64% during the forecast period, 2022-27.

Inflammatory Bowel Disease Treatment Market: Information by Drug Class Disease Indication Distribution Channel, End-User—Forecast 2027

Global gastroesophageal reflux disease therapeutics market size is expected to reach $7.33 Bn by 2028 at a rate of 5.1%, segmented as by type, branded, generic

Infinium Global Research has added a new report on Global Ostomy Care Accessories Market. The report predicts the market size of Ostomy Care Accessories is expected to reach XX billion by 2023.

Infinium Global Research has added a new report on Global Ostomy Care Accessories Market. The report predicts the market size of Ostomy Care Accessories is expected to reach XX billion by 2023.

Global adalimumab, infliximab and etanercept biosimilars market size is expected to reach $6.79 Bn by 2028 at a rate of 11.4%, segmented as by product, adalimumab biosimilars, infliximab biosimilars, cipleumab

The global adalimumab, infliximab and etanercept biosimilars market grew from $4.76 billion in 2022 to $6.24 billion in 2023 at a compound annual growth rate (CAGR) of 31.1%.

The global psoriatic arthritis treatment market is expected to grow at a CAGR of 7.64% during the forecast period of 2023 to 2032. Request Free Sample Report

Global inflammatory bowel disease treatment market size is expected to reach $36.63 Bn by 2028 at a rate of 9.4%, segmented as by drug class, aminosalicylates, corticosteroids, tnf inhibitors, il inhibitors, anti-integrin, jak inhibitors

The new Remicade Biosimilar Market report offers a comprehensive study of the present scenario of the market coupled with major market dynamic. Also, it highlights the in-depth market analysis with the latest trends, drivers and its segments with respect to regional and country. Further, this report profiles top key players of the remicade biosimilar and analyze their market share, strategic development and other development across the globe.

The Global Human Microbiome market is anticipated to grow at a CAGR of 22.41% between 2022 and 2026. Get a free sample report.

The global CT market is growing at a significant rate, due to increasing healthcare expenditure, and growing geriatric population. The increasing prevalence of chronic diseases and improving healthcare infrastructure in developing countries are also driving the growth of the global computed tomography market. However, the factors such as stringent regulatory requirements for the approval of CT devices, and side effects of ionization radiation are inhibiting the growth of the global market.

This report studies the global Sulfasalazine Tablets market status and forecast, categorizes the global Sulfasalazine Tablets market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country. Analysts forecast the global gastrointestinal OTC drugs market to grow at a CAGR of 1.48% over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-gastrointestinal-otc-drugs-2015-2019-market

Major players in the TNF alpha inhibitors market are AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., UCB S.A, Novartis International AG, Pfizer, Inc., Merck & co.... @ @ https://bit.ly/3h9buRa

The global adalimumab, infliximab and etanercept biosimilars market size is expected to grow from $3.10 billion in 2021 to $4.76 billion in 2022 at a compound annual growth rate (CAGR) of 53.4%.

TBRC global inflammatory bowel disease treatment market report includes aminosalicylates, corticosteroids, tnf inhibitors, il inhibitors, anti-integrin, jak inhibitors https://bit.ly/3p5WyWH

Major players in the TNF alpha inhibitors market are AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., UCB S.A, Novartis International AG... @ @ https://bit.ly/3h9buRa